Genetic Mouse Models of Glioma

神经胶质瘤的遗传小鼠模型

基本信息

  • 批准号:
    8839207
  • 负责人:
  • 金额:
    $ 17.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glioblastoma multiforme (GBM) is an aggressive and incurable cancer. The dire prognosis for this most prevalent form of malignant brain tumor is unchanged over 30 years. The Cancer Genome Atlas (TCGA) project has genomically surveyed several hundred human GBM samples and identified a small spectrum of genes that are frequently somatically mutated and include the tumor suppressors NF1, p53 and Pten. We have generated and studied mouse models that spontaneously form classic GBM with 100% incidence. The models are based on somatic mutation of NF1, p53, and Pten. The full penetrance of these tumors has allowed us to probe early pre-tumorigenic events and to identify the adult neural stem cell (NSC) niche as the prevalent source of these tumors. In the previous funding period, we exploited these models to demonstrate a stem cell origin of these tumors and exclude differentiated brain cells as a source. We probed transcriptional profiles to identify glioma-specific upregulation of HoxA genes and examined their function. We developed tools to directly test and demonstrate in vivo the existence of a hierarchical population of cancer stem cells (CSCs) by direct lineage tracing in spontaneous gliomas without resorting to ex vivo transplantation and/or culturing. We unveiled a novel GBM that arises from a different cell of origin. Finally, we developed a novel model of metastatic medulloblastoma that depends on Dicer mutation and is being developed as a separate research initiative. The present proposal embodies two Specific Aims. Aim 1, entitled: "Cancer stem cells in glioma: identification, isolation and characterization." pursues our recent success in transgenically labeling an endogenous glioma cell population that is responsible for tumor recurrence after chemotherapy. We have devised an advanced NSC- and CSC-specific transgene that will co-express Cre recombinase, eGFP, and human diphtheria toxin receptor. This transgene, when bred into the Nf1;p53;Pten floxed background, will permit more precise identification and study of the relatively quiescent CSC population. It will allow purification for quantitative RNA seq analysis i comparison to the non-CSC tumor population, and to the progenitor NSC population. These studies will provide novel information and insight into these newly discovered CSCs. Aim 2 will examine whether "neural progenitor cells (NPCs) and oligodendrocyte progenitor cells (OPCs) give rise to distinct forms of glioma and GBM". We provide evidence that NPCs and OPCs can, by mutations in NF1, p53 and Pten, give rise to gliomas. Mutant NPCs give rise to tumors very similar to the tumors arising in the stem cell compartments whereas OPCs generate an independent form of GBM with distinct molecular, and developmental characteristics. We propose to study these novel tumors in depth since, to the pathologist, they belong to a single GBM pool. Our detailed studies of these tumors may inform human tumor analysis and serve to separate these OPC GBMs that may have different properties, including response to therapies. Genomic, functional, and CSC studies will be pursued for these novel brain tumors.
描述(申请人提供):多形性胶质母细胞瘤(GBM)是一种侵袭性的、无法治愈的癌症。这种最常见的恶性脑肿瘤的可怕预后在30年里没有改变。癌症基因组图谱(TCGA)项目对数百个人类GBM样本进行了基因组调查,并确定了一小部分经常发生体细胞突变的基因,包括肿瘤抑制因子NF1、p53和Pten。我们已经生成并研究了自发形成100%发生率的经典GBM的小鼠模型。该模型基于NF1、p53和Pten的体细胞突变。这些肿瘤的完全外显率使我们能够探索早期的肿瘤发生前事件,并确定成体神经干细胞(NSC)生态位是这些肿瘤的主要来源。在之前的资助期内,我们利用这些模型证明了这些肿瘤的干细胞起源,并排除了分化的脑细胞作为来源。我们研究了转录谱,以鉴定胶质瘤特异性的HoxA基因上调,并检查了它们的功能。我们开发了一种工具,通过在自发性胶质瘤中直接谱系追踪,直接测试和证明癌症干细胞(CSCs)在体内的分层群体的存在,而无需诉诸体外移植和/或培养。我们发现了一种新的GBM,它起源于不同的细胞起源。最后,我们开发了一种新的转移性髓母细胞瘤模型,该模型依赖于Dicer突变,目前正在作为一项单独的研究计划进行开发。本建议有两个具体目标。目标1,题为:“胶质瘤中的癌症干细胞:鉴定、分离和表征”,追求我们最近在转基因标记内源性胶质瘤细胞群方面的成功,这些细胞群负责化疗后的肿瘤复发。我们设计了一种先进的NSC和csc特异性转基因,它将共同表达Cre重组酶、eGFP和人白喉毒素受体。这种转基因,当培育成Nf1, p53;如果背景是固定的,则可以更精确地识别和研究相对静止的CSC群体。它将允许纯化用于定量RNA序列分析,并与非csc肿瘤群体和祖细胞NSC群体进行比较。这些研究将为这些新发现的CSCs提供新的信息和见解。目的2将检查“神经祖细胞(npc)和少突胶质细胞祖细胞(OPCs)是否会引起不同形式的胶质瘤和GBM”。我们提供的证据表明,NPCs和OPCs可以通过NF1、p53和Pten的突变引起胶质瘤。突变的npc产生的肿瘤与干细胞区室中产生的肿瘤非常相似,而OPCs产生的是一种独立形式的GBM,具有不同的分子和发育特征。我们建议深入研究这些新肿瘤,因为对病理学家来说,它们属于单一的GBM池。我们对这些肿瘤的详细研究可以为人类肿瘤分析提供信息,并有助于分离这些可能具有不同特性(包括对治疗的反应)的OPC GBMs。这些新型脑肿瘤的基因组学、功能和CSC研究将继续进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Luis Fernando Parada其他文献

Luis Fernando Parada的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Luis Fernando Parada', 18)}}的其他基金

Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10555234
  • 财政年份:
    2017
  • 资助金额:
    $ 17.92万
  • 项目类别:
Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10337037
  • 财政年份:
    2017
  • 资助金额:
    $ 17.92万
  • 项目类别:
Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10090574
  • 财政年份:
    2017
  • 资助金额:
    $ 17.92万
  • 项目类别:
PROJECT 2: NF1-associated Glioblastoma
项目 2:NF1 相关胶质母细胞瘤
  • 批准号:
    10494106
  • 财政年份:
    2015
  • 资助金额:
    $ 17.92万
  • 项目类别:
PROJECT 2: NF1-associated Glioblastoma
项目 2:NF1 相关胶质母细胞瘤
  • 批准号:
    10270582
  • 财政年份:
    2015
  • 资助金额:
    $ 17.92万
  • 项目类别:
The ability of BDNF in the NAc an VTA in to regulate mood & motivational
NAc 和 VTA 中的 BDNF 调节情绪的能力
  • 批准号:
    8114142
  • 财政年份:
    2010
  • 资助金额:
    $ 17.92万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    8010613
  • 财政年份:
    2009
  • 资助金额:
    $ 17.92万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    8215765
  • 财政年份:
    2009
  • 资助金额:
    $ 17.92万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    7655161
  • 财政年份:
    2009
  • 资助金额:
    $ 17.92万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    7756644
  • 财政年份:
    2009
  • 资助金额:
    $ 17.92万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 17.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了